Michael Barbella, Managing Editor01.27.21
Zebra Medical Vision has developed artificial intelligence technology that can extract precise 3D bone reconstruction from X-rays at the same quality as a CT scan, thus enabling the use of standard X-rays for surgical planning.
The technology recently received U.S. Food and Drug Administration clearance (the company's seventh such approval).
Zebra-Med’s novel technology was recently patented and is expected to transform orthopedic surgery, opening new markets for implants surgeries in places where computed tomography (CT) scans and MRIs are not available or affordable for such procedures.
“The ability to determine implant size cost- effectively (without CT or MRI) will enhance preoperative surgical planning”, said Dr. Charles Lim, total joint replacement expert, Menlo Park, Calif. “This technology can particularly help with less common implant sizes (small or large) and for implant inventory management."
Every year, millions of orthopedic procedures worldwide require CT scans or MRI imaging to assist with pre-operative planning. CT scans and MRI imaging can be expensive, and CT scans are associated with more radiation and are uncomfortable for some patients. Zebra-Med’s technology uses AI algorithms to reconstruct a 3D model of the patient's bones from standard X-ray images, providing orthopedic surgeons full-shape landmarks and measurement information accurately and affordably. Zebra-Med’s ability to create these reconstructions is based on the largest real-world, medical-image database available today.
Zebra-Med’s solution also addresses the logistical bottleneck spurred by unnecessary implants being delivered to each surgery, raising inventory and healthcare costs at large, due to limitations of existing planning solutions.
“Zebra Medical Vision is proud to lead the AI medical imaging market,” said Ohad Arazi, CEO of Zebra Medical Vision. “Expanding from radiology to orthopedic surgery supports our mission of leveraging machine learning and computer vision to help patients achieve better care everywhere with more readily available resources.”
The technology recently received U.S. Food and Drug Administration clearance (the company's seventh such approval).
Zebra-Med’s novel technology was recently patented and is expected to transform orthopedic surgery, opening new markets for implants surgeries in places where computed tomography (CT) scans and MRIs are not available or affordable for such procedures.
“The ability to determine implant size cost- effectively (without CT or MRI) will enhance preoperative surgical planning”, said Dr. Charles Lim, total joint replacement expert, Menlo Park, Calif. “This technology can particularly help with less common implant sizes (small or large) and for implant inventory management."
Every year, millions of orthopedic procedures worldwide require CT scans or MRI imaging to assist with pre-operative planning. CT scans and MRI imaging can be expensive, and CT scans are associated with more radiation and are uncomfortable for some patients. Zebra-Med’s technology uses AI algorithms to reconstruct a 3D model of the patient's bones from standard X-ray images, providing orthopedic surgeons full-shape landmarks and measurement information accurately and affordably. Zebra-Med’s ability to create these reconstructions is based on the largest real-world, medical-image database available today.
Zebra-Med’s solution also addresses the logistical bottleneck spurred by unnecessary implants being delivered to each surgery, raising inventory and healthcare costs at large, due to limitations of existing planning solutions.
“Zebra Medical Vision is proud to lead the AI medical imaging market,” said Ohad Arazi, CEO of Zebra Medical Vision. “Expanding from radiology to orthopedic surgery supports our mission of leveraging machine learning and computer vision to help patients achieve better care everywhere with more readily available resources.”